Assembly Biosciences (ASMB) FCF Margin (QoQ) (2017 - 2026)

Assembly Biosciences (ASMB) FCF Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Assembly Biosciences 431.63 Mn 205.03 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -30,275.00
Dec 31, 2025 17,412.00
Sep 30, 2025 3,344.00
Jun 30, 2025 7,476.00
Mar 31, 2025 -24,332.00
Dec 31, 2024 21,717.00
Sep 30, 2024 -2,212.00
Jun 30, 2024 11,710.00
Mar 31, 2024 -135,647.00
Dec 31, 2020 -247,237.00
Sep 30, 2020 9,986.00
Jun 30, 2020 55,314.00
Mar 31, 2020 -18,643.00
Dec 31, 2019 8,404.00
Sep 30, 2019 16,803.00
Jun 30, 2019 -11,025.00
Mar 31, 2019 -11,927.00
Dec 31, 2018 -6,336.00
Sep 30, 2018 11,139.00
Jun 30, 2018 -6,674.00